IntegraGen has announced today its financial results for the first half of 2020 with the accounts having been reviewed by the Board of Directors on 17 September 2020.
Company posts positive operating performance (EBITDA) for the second consecutive semester, supported by revenue growth (+5%) and confirms strong growth outlook for remainder of 2020.
- Sales revenue of 4.7€ million, up 13% vs. first half of 2019. +15% on a comparable basis (excluding diagnostic activities)
- Positive operating performance (EBITDA) of 0.2€ million compared to a loss of 0.3€ million in H1 2019.